STOCK TITAN

Exec Financial Services (NASDAQ: UTHR) files to sell 50 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC Executive Financial Services reported a proposed sale of 50 shares of common stock (restricted stock) of United Therapeutics Corporation (symbol UTHR) under Form 144.

The filing lists multiple recent small dispositions of 50 shares each on 12/11/2025, 12/23/2025, 01/06/2026, 01/20/2026, 02/03/2026, and 02/17/2026, with per‑trade amounts shown in the excerpt.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 notice showing small, periodic dispositions by an intermediary.

The filing lists a proposed sale of 50 shares of restricted common stock and several recent sales of 50 shares each on specific dates, indicating recurring small transactions. The excerpt ties each transaction to a trade date and a numeric trade amount.

These entries are routine regulatory notices; cash‑flow treatment and broader ownership impacts are not stated in the provided excerpt. Subsequent filings or broker confirmations would disclose executed sale volumes and proceeds.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the UTHR Form 144 filing report?

The filing reports a proposed sale of 50 shares of restricted common stock by Morgan Stanley Smith Barney LLC Executive Financial Services. It also lists multiple recent 50‑share dispositions with trade dates and per‑trade amounts shown in the excerpt.

Who is the filer in the UTHR Form 144?

The filer is Morgan Stanley Smith Barney LLC Executive Financial Services, listed with an address at 1 New York Plaza, 8th Floor, New York, NY. The filing identifies the security as common stock of UTHR.

How many shares does the Form 144 seek to sell for UTHR?

The Form 144 excerpt shows a proposed sale of 50 shares of restricted common stock. The filing also documents several past 50‑share sales on the dates shown in the excerpt.

Are recent sales listed in the UTHR excerpt?

Yes. The excerpt lists multiple recent sales of 50 shares each on 12/11/2025, 12/23/2025, 01/06/2026, 01/20/2026, 02/03/2026, and 02/17/2026, with numeric per‑trade amounts shown.

Does the Form 144 state proceeds or ownership change for UTHR?

The excerpt provides numeric amounts per trade alongside dates but does not state aggregate proceeds or post‑transaction ownership levels. The filing focuses on the proposed sale notice and individual trade entries.
United Therapeutics Corp.

NASDAQ:UTHR

UTHR Rankings

UTHR Latest News

UTHR Latest SEC Filings

UTHR Stock Data

21.85B
42.11M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SILVER SPRING